PP-0102

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePP-0102
Drug Alias NameT-cell receptor modulator (GroPep)PP-0102
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionT-cell surface antigen CD4 inhibitors
TargetsT-cell surface antigen CD4
Therapy Area/IndicationsPsoriasisDermatitisAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovozymes
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovozymes
Active IndicationsN/A
Inactive IndicationsPsoriasisDermatitisAsthma

Other Information

ATC CodeN/A
Related LinksN/A